回复：“当前吸烟与 COVID-19 无关”。
Reply to: "Current smoking is not associated with COVID-19".
机构信息
Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.
Division of Respiratory Medicine, Dept of Medicine, St Paul's Hospital, Vancouver, BC, Canada.
出版信息
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.01340-2020. Print 2020 Jun.
Abstract
相似文献
1
Reply to: "Current smoking is not associated with COVID-19".回复：“当前吸烟与 COVID-19 无关”。
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.01340-2020. Print 2020 Jun.
2
Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2.吸烟会增加严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的受体血管紧张素转换酶2（ACE2）在肺部的基因表达。
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1557-1559. doi: 10.1164/rccm.202003-0693LE.
3
Reply to Letter to the Editor: "COVID-19: is the ACE2 just a foe?".致编辑的信的回复：“COVID-19：血管紧张素转换酶2只是敌人吗？”
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L1031. doi: 10.1152/ajplung.00134.2020.
4
Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'.回复：“2019冠状病毒病背景下肾素-血管紧张素-醛固酮系统抑制剂与血管紧张素转换酶2的相互作用”
Nat Rev Cardiol. 2020 May;17(5):313-314. doi: 10.1038/s41569-020-0369-9.
5
COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors.2019冠状病毒病与慢性阻塞性肺疾病：阻断严重急性呼吸综合征冠状病毒2黏附因子的治疗潜力
Intern Med J. 2020 Sep;50(9):1153-1154. doi: 10.1111/imj.14887. Epub 2020 Jul 14.
6
Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与血管紧张素转换酶2的结合：临床意义
Cardiovasc Res. 2020 Jun 1;116(7):e87-e89. doi: 10.1093/cvr/cvaa096.
7
COVID-19, Renin-Angiotensin System, Angiotensin-Converting Enzyme 2, and Nicotine: What is the Interrelation?新型冠状病毒肺炎、肾素-血管紧张素系统、血管紧张素转换酶2与尼古丁：它们之间有什么相互关系？
Arq Bras Cardiol. 2020 Oct;115(4):708-711. doi: 10.36660/abc.20200653.
8
[Angiotensin-converting enzyme 2 and coronavirus: research update on pathogenesis of the infection induced by this indissoluble bond].[血管紧张素转换酶2与冠状病毒：关于这种不解之缘引发感染的发病机制的研究进展]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):539-545. doi: 10.3760/cma.j.cn112148-20200224-00121.
9
[2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs].[2019新型冠状病毒、血管紧张素转换酶2与心血管药物]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):532-538. doi: 10.3760/cma.j.cn112148-20200308-00171.
10
[Angiotension converting enzyme 2 in the context of 2019 novel coronavirus infection：friend or foe？].2019新型冠状病毒感染中的血管紧张素转换酶2：朋友还是敌人？
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):527-531. doi: 10.3760/cma.j.cn112148-20200303-00149.
引用本文的文献
1
COVID-19 and diet: efforts towards a balanced diet and sustainable nutrition among university students in Pakistan.COVID-19 与饮食：巴基斯坦大学生实现均衡饮食和可持续营养的努力。
PeerJ. 2024 Jan 3;12:e16730. doi: 10.7717/peerj.16730. eCollection 2024.
2
Smoking and COVID-19 in ICU Patients.吸烟与 ICU 患者中的 COVID-19 感染。
Med Arch. 2021 Oct;75(5):356-360. doi: 10.5455/medarh.2021.75.356-360.
3
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome.前瞻性随访 Behçet 综合征患者队列中 COVID-19 的发病、临床特征和结局。
Rheumatol Int. 2022 Jan;42(1):101-113. doi: 10.1007/s00296-021-05056-2. Epub 2021 Nov 25.
4
The effect of smoking on COVID-19-linked biomarkers in hospitalized patients with COVID-19.吸烟对 COVID-19 住院患者中与 COVID-19 相关生物标志物的影响。
J Clin Lab Anal. 2021 Oct;35(10):e23983. doi: 10.1002/jcla.23983. Epub 2021 Aug 31.
5
Smoking cessation during COVID-19: the top to-do list.COVID-19 期间戒烟：首要待办事项清单。
NPJ Prim Care Respir Med. 2021 May 6;31(1):22. doi: 10.1038/s41533-021-00238-8.
6
Smoking and risk of COVID-19 hospitalization.吸烟与 COVID-19 住院风险。
Respir Med. 2021 Jun;182:106414. doi: 10.1016/j.rmed.2021.106414. Epub 2021 Apr 17.
7
COVID-19 and Smoking: What Evidence Needs Our Attention?新冠病毒与吸烟：哪些证据需要我们关注？
Front Physiol. 2021 Mar 18;12:603850. doi: 10.3389/fphys.2021.603850. eCollection 2021.
8
Current developments and future directions in COPD.COPD 的现状和未来发展方向。
Eur Respir Rev. 2020 Dec 2;29(158). doi: 10.1183/16000617.0289-2020. Print 2020 Dec 31.
9
Smoking and COVID-19: Adding Fuel to the Flame.吸烟与新冠病毒：火上浇油
Int J Mol Sci. 2020 Sep 9;21(18):6581. doi: 10.3390/ijms21186581.
10
Evidence-Based Considerations Exploring Relations between SARS-CoV-2 Pandemic and Air Pollution: Involvement of PM2.5-Mediated Up-Regulation of the Viral Receptor ACE-2.基于证据的考虑因素：探索 SARS-CoV-2 大流行与空气污染之间的关系：PM2.5 介导的病毒受体 ACE-2 上调的作用。
Int J Environ Res Public Health. 2020 Aug 2;17(15):5573. doi: 10.3390/ijerph17155573.
本文引用的文献
1
Clinical Characteristics of Covid-19 in New York City.纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
2
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.吸烟者和 COPD 患者小气道上皮中的 ACE-2 表达：对 COVID-19 的影响。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00688-2020. Print 2020 May.
3
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
4
COVID-19: the medium is the message.新冠疫情：媒介即信息。
Lancet. 2020 Mar 21;395(10228):942-943. doi: 10.1016/S0140-6736(20)30600-0. Epub 2020 Mar 11.
5
How to fight an infodemic.如何应对信息疫情。
Lancet. 2020 Feb 29;395(10225):676. doi: 10.1016/S0140-6736(20)30461-X.
6
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件